Pyrimethamine labels and packages: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Pyrimethamine}} | {{Pyrimethamine}} | ||
{{CMG}}; {{AE}} {{chetan}} | {{CMG}}; {{AE}} {{chetan}} | ||
==Labels and Packages== | |||
PRINCIPAL DISPLAY PANEL – NDC 52054-330-10<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = DARAPRIM (PYRIMETHAMINE) TABLET [AMEDRA PHARMACEUTICALS LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3e4d5027-7939-480f-ae19-82e764d9fa97#nlm34089-3 | publisher = | date = | accessdate = }}</ref> | PRINCIPAL DISPLAY PANEL – NDC 52054-330-10<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = DARAPRIM (PYRIMETHAMINE) TABLET [AMEDRA PHARMACEUTICALS LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3e4d5027-7939-480f-ae19-82e764d9fa97#nlm34089-3 | publisher = | date = | accessdate = }}</ref> | ||
Latest revision as of 01:14, 10 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Labels and Packages
PRINCIPAL DISPLAY PANEL – NDC 52054-330-10[1]
| [[File:|800px|thumb]] |
References
Adapted from the FDA Package Insert.